Navigation Links
Big Decline in Heart Attacks If All States Had Smoking Bans
Date:5/20/2010

Americans would suffer 18,000 fewer attacks per year, save millions in health costs, study finds

THURSDAY, May 20 (HealthDay News) -- If all states banned smoking in restaurants, offices and other public spaces nationwide, the number of Americans suffering from heart attacks would drop by more than 18,000 within the first year, researchers report.

"Comprehensive smoking bans have been implemented in some states, but not in every state," noted lead researcher Dr. Mouaz Al-Mallah, co-director of Cardiac Imaging Research at Henry Ford Hospital, in Detroit.

Currently, 39 states have some type of public smoking bans, with 26 banning smoking in any enclosed public space, while 11 states have no bans at all.

Based on the finding, Al-Mallah said that he would "encourage all states to institute a ban on smoking in public place to protect people from secondhand smoke. Authorities should do everything possible to prevent healthy individuals from being exposed to secondhand smoke, and one of the ways is by passing such laws. "

Al-Mallah was scheduled to present the findings Thursday at the American Heart Association's annual Quality of Care and Outcomes Research conference in Washington, D.C.

For the study, the researchers looked at data from 13 states that do not have laws banning smoking in public places. In states without smoking bans there were 169,043 hospitalizations for heart attack, the researchers found.

Based on their calculations of an 11 percent drop in heart attacks if bans were instituted nationwide, there would be 18,596 fewer hospitalizations for heart attack in the first year.

In addition, there would be a savings of $92 million in costs of caring for these patients, the researchers said.

In 2008, Al-Mallah found that a smoking ban in Michigan would result in a 12 percent drop in heart attacks in that state.

Dr. Gregg C. Fonarow, director of the Ahma
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Cautious Optimism Begins, Pessimism Declines on U.S. and Global Economies Among U.S. Industrial Manufacturers, According to PricewaterhouseCoopers Q4 2009 Manufacturing Barometer
2. Decade of Decline in U.S. Teen Pregnancies Ends
3. New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts
4. U.S. Swine Flu Cases Chart Sharp Decline
5. Breast Cancer Decline Only Partly Due to HRT
6. New figures on cancer in Europe show a steady decline in mortality but big variations
7. Disability may be on the rise again after 20-year decline
8. Elderly Report Rising Rates of Disability After 20-Year Decline
9. Ginkgo Wont Slow Decline of Aging Brain
10. Physician Satisfaction with Electronic Medical Records Declines
11. Sexual function does not continuously decline after radiation therapy treatments for prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... Richmond, Va. (May 22, 2012) Scientists ... be one step closer to developing a new ... that the targeted agents obatoclax and sorafenib kill ... when the drugs are administered individually., Recently published ... study led by Steven Grant, M.D., Shirley Carter ...
(Date:5/22/2012)... It,s quite common for a female song sparrow to ... male next door, but a new study shows that ... which is reported in The American Naturalist, ... on to have lower reproductive success than within-pair offspring. ... why ostensibly monogamous animals might be inclined to cheat. ...
(Date:5/22/2012)... the Medical College of Wisconsin have identified novel biomarkers ... radiation in large groups of people potentially exposed to ... and treatment. , The findings are published in the ... John E. Baker, Ph.D., professor of surgery, biochemistry, pharmacology ... the lead author of the study. , There is ...
(Date:5/22/2012)... weight-loss products are the types of dietary supplements most ... new study. Liver injury from medication is the ... and herbal supplements -- which do not require a ... online -- are used by up to 40 percent ... side effects are not well-known. In this study, ...
(Date:5/22/2012)... care units (ICUs) that have no or limited access ... patient outcomes by having the specialists, called intensivists, staff ... by researchers at the University of Pittsburgh School of ... find any incremental benefit of nighttime staffing in ICUs ... day. The findings were published online today in the ...
Breaking Medicine News(10 mins):Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 3Health News:For monogamous sparrows, it doesn't pay to stray (but they do it anyway) 2Health News:Body Building, Diet Supplements Linked to Liver Damage: Study 2Health News:Intensivists at night improve patient outcomes in some ICUs, says Pitt/UPMC team 2
... to eradicate fatal parasite; first vaccines delivered following major ... Melbourne researchers that could eradicate a fatal form of ... and could soon be commercially available thanks to multi-million ... causes 50 million tapeworm infections and 50,000 deaths from ...
... financial results -, LAVAL, QC, Oct. 29 /PRNewswire-FirstCall/ ... it will host a conference call on,Friday, November 7 ... 2008,financial results. Labopharm will report its third quarter 2008 ... same day., To access the conference call by ...
... Arizona Market, NORTH HOLLYWOOD, Calif., Oct. 29 ... ), a leading national physician,group practice company, announced ... in Mesa, Arizona. The group has an ongoing ... hospitalist,services to the PHO,s patients in the Phoenix ...
... Montague,("Berger") announced today that a class action lawsuit was ... on behalf of all purchasers of,American Depository Shares (evidenced ... the "Company") and all purchasers of,options to purchase Elan ... 29, 2008 (the "Class Period") charging Elan and certain ...
... of America, Inc.,(OTC Bulletin Board: CPCF), a company ... in endovascular procedures, today announced,that it is implementing ... its MedClose(TM) investigational-stage medical device. In,the roll out ... Medical,Product Service GmbH (MPS) of Germany to act ...
... Japan-based Sato Sports Plaza to investigate new muscle,training ... effort to expand,global health and fitness research and ... formed an international science and health,exchange to highlight ... program with Sato Sports Plaza of,Japan is the ...
Other Medicine News:Health News:Fight begins to eradicate fatal parasite; first vaccines delivered following major funding award 2Health News:Fight begins to eradicate fatal parasite; first vaccines delivered following major funding award 3Health News:Labopharm to host conference call Friday, November 7, 2008 at 8:30 a.m. (ET) 2Health News:IPC The Hospitalist Company Acquires Phoenix Area Practice 2Health News:Berger & Montague Announces Class Action Lawsuit Against Elan Corporation 2Health News:Berger & Montague Announces Class Action Lawsuit Against Elan Corporation 3Health News:Berger & Montague Announces Class Action Lawsuit Against Elan Corporation 4Health News:CPC Appoints Medical Product Service GmbH as Authorized European Representative for MedClose(TM) System 2Health News:CPC Appoints Medical Product Service GmbH as Authorized European Representative for MedClose(TM) System 3Health News:New Program Internationalizes Health and Fitness Research 2
(Date:5/22/2012)... -- SmallCapVoice.com, Inc. announced today that a ... (PINKSHEETS: MJNA) is now available. The interview ... Recent company activity and highlights: ... of approximately $1.21 million on gross revenues ... March 31, 2012.  This represents a gross ...
(Date:5/22/2012)... Company (Nasdaq: PRGO;TASE) today announced that it has ... Drug Administration for its abbreviated new drug application ... generic equivalent of Gynazole·1®. Perrigo was the first applicant ... paragraph IV certification and is entitled to 180-days ... Pharmaceutical Company on a collaboration to launch the ...
(Date:5/22/2012)... May 22, 2012 Prime Therapeutics (Prime), a ... hired Jim DuCharme as chief financial officer (CFO). DuCharme ... company,s foundation for continued growth. "Jim brings ... of driving business performance within diverse health plans, including ... president and CEO at Prime. "Based on his strong ...
Breaking Medicine Technology:Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 2Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 3Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 4Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3Osteotech Reports Third Quarter 2009 Financial Results 6039 1Osteotech Reports Third Quarter 2009 Financial Results 6039 2Osteotech Reports Third Quarter 2009 Financial Results 6039 3Osteotech Reports Third Quarter 2009 Financial Results 6039 4Osteotech Reports Third Quarter 2009 Financial Results 6039 5Osteotech Reports Third Quarter 2009 Financial Results 6039 6Osteotech Reports Third Quarter 2009 Financial Results 6039 7Osteotech Reports Third Quarter 2009 Financial Results 6039 8November 2009 story tips from the US Department of Energys Oak Ridge National Laboratory 14746 1November 2009 story tips from the US Department of Energys Oak Ridge National Laboratory 14746 2November 2009 story tips from the US Department of Energys Oak Ridge National Laboratory 14746 3Research Findings Key for Understanding Interpreting Genetic Testing for Long QT Syndrome 60803 1Research Findings Key for Understanding Interpreting Genetic Testing for Long QT Syndrome 60803 2Research Findings Key for Understanding Interpreting Genetic Testing for Long QT Syndrome 60803 3
... SAN FRANCISCO, Calif., July 22 Hyperion,Therapeutics, ... patient enrollment,in its Phase 1/2 clinical trial ... effects of HPN-100 (formally called GT4P) versus,BUPHENYL(R) ... disorders,(UCD). The company plans to announce top-line ...
... Includes an Individual,s Genetic Risk Based on Clinical ... Scientific Educational Materials, WALTHAM, Mass., July 22 ... announced the launch of an enhanced test report,format ... Genetic Test.,The test is currently marketed under the ...
Other Medicine Technology:Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use....
Used when establishing a percutaneous tract for nephrostomy drainage. The guide has a stiff shaft and a gradual transition to a very flexible distal tip. Supplied sterile in peel-open packages. Inten...
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: